Literature DB >> 23564085

Autophagy modulation as a target for anticancer drug discovery.

Xin Li1, Huai-long Xu, Yong-xi Liu, Na An, Si Zhao, Jin-ku Bao.   

Abstract

Autophagy, an evolutionarily conserved catabolic process involving the engulfment and degradation of non-essential or abnormal cellular organelles and proteins, is crucial for homeostatic maintenance in living cells. This highly regulated, multi-step process has been implicated in diverse diseases including cancer. Autophagy can function as either a promoter or a suppressor of cancer, which makes it a promising and challenging therapeutic target. Herein, we overview the regulatory mechanisms and dual roles of autophagy in cancer. We also describe some of the representative agents that exert their anticancer effects by regulating autophagy. Additionally, some emerging strategies aimed at modulating autophagy are discussed as having the potential for future anticancer drug discovery. In summary, these findings will provide valuable information to better utilize autophagy in the future development of anticancer therapeutics that meet clinical requirements.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564085      PMCID: PMC4002878          DOI: 10.1038/aps.2013.23

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  132 in total

1.  Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.

Authors:  Xuxian Xiao; Qiongqiong He; Changming Lu; Kaitlin D Werle; Rui-Xun Zhao; Jianfeng Chen; Ben C Davis; Rutao Cui; Jiyong Liang; Zhi-Xiang Xu
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

2.  Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions.

Authors:  Kyoung Min Kim; Tack Keun Yu; Hyun Hee Chu; Ho Sung Park; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Min Ho Kim; Ju Hyung Lee; Myoung Ja Chung
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

3.  microRNA-101 is a potent inhibitor of autophagy.

Authors:  Lisa B Frankel; Jiayu Wen; Michael Lees; Maria Høyer-Hansen; Thomas Farkas; Anders Krogh; Marja Jäättelä; Anders H Lund
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

4.  Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.

Authors:  Camilla Evangelisti; Francesca Ricci; Pierluigi Tazzari; Francesca Chiarini; Michela Battistelli; Elisabetta Falcieri; Andrea Ognibene; Pasqualepaolo Pagliaro; Lucio Cocco; James A McCubrey; Alberto M Martelli
Journal:  J Cell Physiol       Date:  2011-03       Impact factor: 6.384

Review 5.  Autophagic pathways as new targets for cancer drug development.

Authors:  Bo Liu; Yan Cheng; Qian Liu; Jin-ku Bao; Jin-Ming Yang
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

Review 6.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

7.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

8.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

9.  Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability.

Authors:  Mi Ran Kang; Min Sung Kim; Ji Eun Oh; Yoo Ri Kim; Sang Yong Song; Sung Soo Kim; Chang Hyeok Ahn; Nam Jin Yoo; Sug Hyung Lee
Journal:  J Pathol       Date:  2009-04       Impact factor: 7.996

10.  Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens.

Authors:  Jörn Dengjel; Maria Høyer-Hansen; Maria O Nielsen; Tobias Eisenberg; Lea M Harder; Søren Schandorff; Thomas Farkas; Thomas Kirkegaard; Andrea C Becker; Sabrina Schroeder; Katja Vanselow; Emma Lundberg; Mogens M Nielsen; Anders R Kristensen; Vyacheslav Akimov; Jakob Bunkenborg; Frank Madeo; Marja Jäättelä; Jens S Andersen
Journal:  Mol Cell Proteomics       Date:  2012-02-06       Impact factor: 5.911

View more
  19 in total

1.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

2.  G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro.

Authors:  Peng-xing He; Yong-sheng Che; Qiao-jun He; Yi Chen; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

3.  On-chip clearing of arrays of 3-D cell cultures and micro-tissues.

Authors:  S M Grist; S S Nasseri; T Poon; C Roskelley; K C Cheung
Journal:  Biomicrofluidics       Date:  2016-07-20       Impact factor: 2.800

Review 4.  Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.

Authors:  Lan Zhang; Xupeng Tong; Jingjing Li; Yue Huang; Xinyue Hu; Yi Chen; Jian Huang; Jinhui Wang; Bo Liu
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

5.  Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.

Authors:  Fang Liu; Yue Shang; Shu-zhen Chen
Journal:  Acta Pharmacol Sin       Date:  2014-04-14       Impact factor: 6.150

6.  Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma.

Authors:  Takeo Nitta; Yasunori Sato; Xiang Shan Ren; Kenichi Harada; Motoko Sasaki; Satoshi Hirano; Yasuni Nakanuma
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.

Authors:  Fan Xuan; Mengying Huang; Wen Liu; Hanfei Ding; Liqun Yang; Hongjuan Cui
Journal:  Neuro Oncol       Date:  2015-11-17       Impact factor: 12.300

8.  Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species.

Authors:  Haiqing Wang; Ting Liu; Lu Li; Qin Wang; Chunrong Yu; Xin Liu; Wenhua Li
Journal:  Cell Biosci       Date:  2015-01-14       Impact factor: 7.133

9.  Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells.

Authors:  Ting Liu; Qiuxu Men; Guixian Wu; Chunrong Yu; Zan Huang; Xin Liu; Wenhua Li
Journal:  Oncotarget       Date:  2015-04-10

10.  Anticancer activities of self-assembled molecular bowls containing a phenanthrene-based donor and Ru(II) acceptors.

Authors:  Inhye Kim; Young Ho Song; Nem Singh; Yong Joon Jeong; Jung Eun Kwon; Hyunuk Kim; Young Mi Cho; Se Chan Kang; Ki-Whan Chi
Journal:  Int J Nanomedicine       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.